Cite

HARVARD Citation

    Liang, J. et al. (2021). Designed, synthesized and biological evaluation of proteolysis targeting chimeras (PROTACs) as AR degraders for prostate cancer treatment. Bioorganic & medicinal chemistry. p. . [Online]. 
  
Back to record